Treatment of Mania Symptoms With Drug Therapy
Completed · Phase 3 · Has a placebo group
Conditions studied: Bipolar Disorder, Schizophrenia
In brief
This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
Key facts
- Study ID
- NCT00183443
- Run by
- Palo Alto Veterans Institute for Research
- People needed
- 75
- Starts
- 2005-02-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2018-07-17
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of bipolar I disorder or schizophrenia
- Experiencing symptoms of mania at study entry
- Able to speak and understand English
- Willing and able to comply with all study requirements
You may not qualify if…
- History of partial response or nonresponse to any of the drugs or drug combinations given in this study
- History of intolerance to DVP, DVP-ER, lithium, or quetiapine
- Disorders that would contraindicate the use of DV, DV-ER, lithium, or quetiapine
- Use of antidepressants within 1 month prior to study entry
- Use of fluoxetine within 3 months prior to study entry
- Impaired cardiac function, as evidenced by abnormal EKG in participants 50 or over
- Unstable medical illness within 2 months prior to study entry
- At risk for suicide
- Substance abuse or dependence within 1 month prior to study entry
- Pregnancy, breastfeeding, or plans to become pregnant during the study
Where it is running
- VA Palo Alto Health Care System — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.